Ingen Technologies Syndicated With America's #1 Educational Healthcare Television Series

Ingen Technologies Syndicated With America's #1 Educational Healthcare Television Series

- IGTN Reaches 75% of the Households in the US -

CALIMESA, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Ingen Technologies, Inc. , a medical device manufacturer of OxyAlert(TM), OxyView(TM), Secure Balance(TM), and Pure Produce(TM), announces the signed Contract between the Delray Beach-Florida based Five Star Productions U.S.A., Inc. to syndicate the advertising of all of its product lines with Today's Health(R), the television series hosted by tennis pro Chris Evert.

Now in its 11th season, Today's Health(R) provides an exciting look at the latest innovations in medicine and healthcare. The show airs via national syndication, reaching 75% of the U.S. households, typically during late mornings and afternoon time periods on weekends, and primarily on ABC, CBS, MSNBC and Fox affiliates. Each of the Ingen infomercials will be TV Guide listed. Additionally, the show is broadcast by satellite on the Dish Network -- on Turner Media Group's Healthy Living Channel which is delivered to an additional 12.3 million households. The IGTN infomercial will air at least two times during Prime Time.

The IGTN product segment will be promoted individually across all 9 Turner Media Group channels, including The Men's Channel, The Beauty & Fashion Channel, and iShop TV. Further, Today's Health(R) has included a one minute Radio News Story of IGTN that will be produced as a part of a 30 minute syndicated radio program, broadcast on over 400, primarily FM Radio, stations nation-wide.

GE Medical Systems TiP-TV distributes Today's Health(R) to over 1,600 hospitals, reaching hundreds of thousands of patients, physicians and nurses. "With OxyView(TM) and OxyAlert close to completion, and Secure Balance(TM) sales increasing, Today's Health(R) will certainly deliver a strong and viable message to our markets," said Scott Sand, CEO and Chairman of Ingen Technologies, Inc.

About Ingen Technologies, Inc.

Ingen Technologies, Inc. is a public company trading under NASDAQ OTC:IGTN, which has been in business since 1999. IGTN is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.

The Company's flagship product is OxyAlert(TM), a second-generation design of the Company's BAFI(TM) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.

The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow to hospitalized patients. This product enhances the safety, assurance and accuracy of hospitalized patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of oxygen flow rate near the patient. It could quickly inform the hospital staff of any leak or inaccuracy between the delivery source and the patient.

The Secure Balance(TM) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics (LTD) in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.

The Pure Produce(TM) product is a continuing research & development program currently under design. This program uses hydroponic and airoponic technology to grow various produce and other plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.

"Our team of professionals continues to develop medical products for the ever-increasing elderly population. Our products offer cost-containment for Medicare costs, and are superior to any of our competition as they allow for effective medical product availability to seniors; and at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.

For more information, visit www.ingen-tech.com

Investor Relations Contact: Scott R. Sand, C.E.O. & Chairman Ingen Technologies, Inc. - Administrative Office 35193 Avenue "A", Suite-C Yucaipa, California 92399 Phone: (800) 259-9622 or (951) 675-3266 Fax: (800) 777-1186 or (909) 795-6340 Email: Info@ingen-tech.com A Member of the Better Business Bureau A Member of the Chamber of Commerce A Licensed Business in the City of Yucaipa

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Source: Ingen Technologies, Inc.

CONTACT: Investor Relations, Scott R. Sand, C.E.O. & Chairman of Ingen Technologies, Inc., +1-800-259-9622 or +1-951-675-3266, or Fax, +1-800-777-1186 or +1-909-795-6340, Info@ingen-tech.com

Web site: http://www.ingen-tech.com/

------- Profile: Ent